FIELD: medicine.
SUBSTANCE: invention relates to pharmacokinetics and concerns the method for improving biological availability of ospemifene or its geometrical isomer, stereoisomer, pharmaceutically acceptable salt, ester or metabolite where ospemifene is administered orally to an individual between 1 h before meals and 2 h after meal.
EFFECT: invention provides improved bioavailability of ospemifene.
14 cl, 3 dwg, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR INHIBITION OF ATROPHY OR TREATMENT OR PROPHYLAXIS OF SYMPTOMS RELATES TO ATROPHY IN WOMEN | 2003 |
|
RU2317816C2 |
| SOLID PREPARATIVE FORMS OF OSPEMIFENE | 2005 |
|
RU2423113C2 |
| SOLID FORMULATIONS OF OSPEMIFENE | 2005 |
|
RU2675624C2 |
| METHOD FOR TREATING CLIMACTERIC DISORDERS IN WOMEN EITHER DURING OR AFTER MENOPAUSE | 2001 |
|
RU2268035C2 |
| SOLID DISPERSIONS | 2016 |
|
RU2694832C2 |
| SOLID COMPOSITIONS BASED ON BETAHISTINE FOR ORAL ADMINISTRATION WITH NON-PULSATING PROLONGED RELEASE | 2018 |
|
RU2774644C2 |
| INCREASE IN BIOAVAILABILITY OF DRUGS IN THERAPY WITH NALTREXONE | 2011 |
|
RU2781141C2 |
| METHODS OF TREATING GASTROINTESTINAL TRACT DISORDERS INDEPENDENTLY ON FOOD CONSUMPTION | 2014 |
|
RU2563993C1 |
| METHOD OF WEIGHT REDUCTION AND HEALTH IMPROVEMENT | 2010 |
|
RU2482885C2 |
| METHOD FOR CORRECTION OF ABDOMINAL OBESITY | 2013 |
|
RU2525007C1 |
